Evidence-Based Risk Stratification to Target Therapies in Acute Coronary Syndromes
نویسندگان
چکیده
منابع مشابه
Evidence-based risk stratification to target therapies in acute coronary syndromes.
The approach to risk stratification has evolved during the past 2 decades from a practice that once involved an evaluation for residual ischemia and for left ventricular dysfunction after myocardial infarction (MI). However, risk stratification has now evolved more to include assessment of the risk of future cardiac events, which can be predicted on the basis of clinical features at the time of...
متن کاملAcute coronary syndromes: risk stratification.
syndromes aims to identify those patients at greatest risk of recurrent ischaemic events who might benefit prognostically from further investigation and treatment. Unfortunately, however, none of the clinical or investigative markers currently available has suYcient diagnostic power to identify all high risk patients while excluding those at negligible risk. Moreover, for patients judged to be ...
متن کاملRisk stratification in acute coronary syndromes.
In acute coronary syndromes, risk stratification is essential, particularly in those without ST-elevation, and is based upon clinical and biological markers. Among them, recent and repeated anginal attacks, ST-segment modifications on admission electrocardiogram, and increased markers of myonecrosis (particularly increased troponine levels) are strong predictors of untoward outcome. These varia...
متن کاملRisk stratification with cardiac troponin I in acute coronary syndromes.
Recent years have shown a rapidly growing interest among clinical chemists, clinical cardiologists and emergency physicians in the use of new biochemical markers for risk stratification of patients with acute coronary syndrome (ACS). It was demonstrated across a wide range of ACS patient populations (including low-, intermediate-, and high-risk) that evidence of myocardial injury upon presentat...
متن کاملRisk Stratification and Therapeutic Decision Making in Acute Coronary Syndromes
with an acute STEMI, the optimal treatment is usually clear-proceed to PCI immediately. The situation is less clear with unstable angina and NSTEMI's, a heterogeneous group of acute coronary syndromes with a wide spectrum of risk for death and cardiac ischemic events. Prognostication of risk in these patients is critical as it can dictate optimal therapy and location of treatment (outpatient vs...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Circulation
سال: 2002
ISSN: 0009-7322,1524-4539
DOI: 10.1161/01.cir.0000030416.80014.f4